Lechleider Robert 4
4 · Immunome Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Lechleider Robert
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2023-10-27+400,000→ 400,000 totalExercise: $8.73Exp: 2033-10-26→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on October 16, 2024, and the remaining shares will vest monthly thereafter over three years.